3 Ways Valeant Turned Allergan Misfire Into Salix Victory

By Benjamin Horney (March 16, 2015, 6:13 PM EDT) -- Valeant Pharmaceuticals International Inc. threw down the hammer Monday when it increased its offer to acquire Salix Pharmaceuticals Ltd. to about $15.8 billion including debt, causing Endo Pharmaceuticals Inc. to drop out of what had become a monthlong battle to buy the gastrointestinal treatment developer....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!